HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Cardiopulmonary Rehabilitation and Prevention
Cardiopulmonary Rehabilitation and Prevention
Cardiopulmonary Rehabilitation:
Rehabilitation is a comprehensive therapeutic and instructional programme created for individuals suffering from cardiopulmonary illnesses or following post-cardiac surgery, with the goal of restoring heart health and job capacity while minimizing impairment impact. The other goals are to manage the symptoms and improve overall quality of life.
Prevention: There are numerous methods for preventing heart and lung problems. However, high blood pressure/hypertension is one of the key risk factors for cardiac disorders.
The following are some preventive measures:
- regulating blood pressure
- by controlling triglycerides and cholesterol - by maintaining a healthy weight
- a nutritious diet - daily exercise
- No smoking is permitted.
- control diabetes
- get adequate sleep
Committee Members
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation